meprylcaine

This page covers all meprylcaine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channel alpha subunits; brain (Types I, II, III).

Targets

Sodium channel alpha subunits; brain (Types I, II, III)

Phase 2 pipeline (1)

• Oracaine · Neuroscience
  Oracaine works by blocking sodium channels in the brain to prevent the transmission of nerve impulses.

Patent intelligence

• meprylcaine patent landscape — aggregated cliff calendar, attackable patents, originator estates